Health

Fourth COVID-19 booster shot for over 50s in Saudi Arabia now available

Saudi Arabia has started providing a fourth COVID-19 booster dose for those over 50 years of age, the Kingdom’s Ministry of Health announced on Tuesday.

The fourth dose is available for those above 50 who have cleared eight months since the first booster shot.

For the latest headlines, follow our Google News channel online or via the app.

It can be availed through an appointment on the Sehhaty mobile application, the official Saudi Press Agency reported.

The Kingdom has actively combated the spread of COVID-19 by providing free and easily available COVID-19 vaccinations, strict social safety rules, and frequent testing mandates for residents and travelers.

Read the latest updates in our dedicated coronavirus section.

As of April 25, Saudi Arabia reported 109 new cases and one death from the virus. Total deaths from COVID-19 stand at 9,082, according to the health ministry.

Over 24 million people are fully vaccinated, and over 64 million doses have been administered country wide.

WHO chief says we are ‘increasingly blind’ on COVID-19 transmission

Beijing residents panic buy as district undergoes mass testing for COVID-19

Health

‘Just in case’ use of antibiotics was rife during COVID-19, says UN health agency

Antibiotics saw “extensive overuse” globally among hospitalized COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially exacerbating the already serious and growing threat of antimicrobial resistance, the UN World Health Organization (WHO) said on Friday.

Health

Teen alcohol and nicotine use in Europe is up, WHO urges preventive measures

Substance use is on the rise among teenagers in Europe, Central Asia and Canada and girls now match or even exceed boys when it comes to smoking and drinking, the World Health Organization (WHO) said in a new report on Thursday.

Health

Gender therapy review reveals devastating impacts on teens

A top Human Rights Council-appointed expert has welcomed the decision by all health authorities in the United Kingdom to halt the routine use of puberty-blockers offered to children as part of gender transition services, amid a sharp increase more widely in the number of teenage girls seeking such treatment and concerns that it might disrupt brain development.